Research
Holos Is One of the Partners in the CLARIFY Project
CLARIFY aims to integrate and analyse large volumes of heterogeneous, multivariate data to make it easier to detect, at an early stage, risk factors that can worsen a patient's condition after cancer treatment. This will effectively help to stratify cancer survivors by risk, in order to personalise their follow-up through a better assessment of their needs.
Big Data and Artificial Intelligence techniques will be used to integrate all available patient information with relevant, publicly available biomedical databases, as well as data from wearable devices used after treatment.